Publication | Closed Access

Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats

HypertensionCerebrovascular DiseaseCerebral Vascular RegulationThrombosisStrokeNeurologyPublic HealthAtherosclerosisIschemic SyndromeLong-term AdministrationVascular BiologyCerebral Blood FlowReperfusion InjuryPharmacologyCardiovascular DiseaseIschemic StrokePhysiologyStroke EventsMedicineHmg-coa Reductase Inhibitor